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Increased carbonyl modification by lipids and carbohydrates Advanced glycation end products accumulate in
in diabetic nephropathy. plasma and tissue proteins of diabetic patients [1, 2],
Background. In diabetic nephropathy (DN), possible medi- and their accumulation is correlated with the severity ofators of untoward effects of hyperglycemia include the ad-
diabetic complications [2, 3]. AGEs comprise a variety ofvanced glycation end products (AGEs). Indeed, an AGE, car-
molecular structures, such as Ne-(carboxymethyl)lysineboxymethyllysine (CML), accumulates in expanded mesangial
matrix and nodular lesions. An advanced lipoxidation end (CML), pentosidine, and pyrraline, which are character-
product (ALE), malondialdehyde-lysine (MDA-lysine), gener- ized by different formation mechanisms. Glycoxidation
ated on proteins during lipid peroxidation also accumulates in
products, a subclass of AGEs that requires both glycationthese lesions. As both ALEs and AGEs are formed by carbonyl
and oxidation for their formation, such as CML andamine chemistry between protein and carbonyl compounds
derived from autoxidation of lipids and carbohydrates, their pentosidine, accumulate in expanded mesangial matrix
colocalization suggests an increased carbonyl modification of and nodular lesions in DN [4]. By contrast, pyrraline,
proteins. another AGE structure in which the deposition is ratherMethods. To address this hypothesis, human diabetic renal
independent from oxidative stress, was not found withintissues were examined to characterize carbonyl modification
diabetic glomeruli. Interestingly, the distribution of ma-of proteins by lipids and carbohydrates: (a) ALEs, MDA-lysine
and 4-hydroxynonenal (HNE) protein adduct, derived from londialdehyde (MDA)-lysine, an advanced lipoxidation
lipids, and (b) AGEs, pentosidine and CML, derived from end product (ALE), colocalized with the CML and pen-
carbohydrates. Furthermore, to elucidate the biological effect
tosidine distribution. We therefore hypothesized that theof carbonyl modification on primary cultured human and rat
localization of CML, pentosidine, and MDA-lysine, inmesangial cells, the intracellular protein phosphorylation was
examined in the presence of various kinds of carbonyl com- which the formation is closely related to oxidative pro-
pounds. cess, is independent evidence for a local oxidative stress
Results. The ALE and AGE adducts examined were identi- in diabetic glomerular lesions [4].fied in expanded mesangial matrix and nodular lesions. The
exposure of cultured mesangial cells to carbonyl compounds
resulted in phosphorylation of tyrosine residues of a number
INCREASED CARBONYL MODIFICATION OFof intracellular proteins.
GLOMERULAR PROTEINS BY LIPIDS ANDConclusions. These data suggest a broad derangement in
nonenzymatic biochemistry involving both lipids and carbohy- CARBOHYDRATES: “CARBONYL STRESS”
drates exists in diabetic glomerular lesions (“carbonyl stress”).
Under oxidative stress, proteins may be modified ei-
ther directly by reactive oxygen species with the eventual
formation of oxidized amino acids or indirectly by reac-Diabetic nephropathy (DN) has become one of the
tive carbonyl compounds formed by autoxidation of car-main causes of end-stage renal disease. The metabolic
bohydrates and lipids. Both AGEs and MDA-lysine areevents responsible for its development are not under-
indeed products formed by carbonyl amine chemistrystood well. Possible mediators of untoward effects of
between protein amino group and carbonyl compoundshyperglycemia include the advanced glycation end prod-
derived from autoxidation of carbohydrates and lipidsucts (AGEs) generated by nonenzymatic glycation and
(see [5] for a review of the structures of carbonyl com-oxidation reactions.
pounds and their final protein adducts). Autoxidation
of carbohydrates yields reactive carbonyl compounds,
Key words: diabetes, advanced glycation end products, advanced lipox-
precursors of AGEs, such as glyoxal, arabinose, and gly-idation end product, reactive carbonyl compound, oxidative protein
damage. colaldehyde, as well as dehydroascorbate formed on oxi-
dation of ascorbate [5]. Lipid peroxidation yields other 1999 by the International Society of Nephrology
S-54
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Fig. 1. Immunohistochemical detection of advanced glycation end product (AGE; A-C) and advanced lipoxidation end product (ALE; D-F) in
diabetic glomerular lesions. Both carboxymethyllysine (CML; AGE) and malondialdehyde (MDA)-lysine (ALE) were identified in the expanded
mesangial area (A and D) and in nodular lesions (B and E) of diabetic nephropathy, whereas their immunostainings were faint in nondiabetic
normal glomeruli (C and F). Anti-AGE mouse monoclonal IgG (6D12), the major epitope structure of which was identified as CML, and anti-
MDA-lysine mouse monoclonal IgG (kindly provided from Dr. Joseph L. Witztum) were used for immunohistochemistry. The characterization
of the antibodies was described previously [4]. The specificity of immunostaining was confirmed by competition experiments with either anti-CML
or anti-MDA-lysine antibody preincubated with an excess of CML-bovine serum albumin or MDA-bovine serum albumin, respectively (original
magnification 3200).
reactive carbonyl compounds, such as MDA and human diabetic renal tissues were examined with specific
antibodies to characterize carbonyl modification of pro-4-hydroxynonenal (HNE). These carbonyl compounds
form ALEs on proteins, such as MDA-lysine and HNE teins by autoxidation products of carbohydrates and lip-
ids in (a) AGEs (CML and pentosidine), derived mainlyprotein adduct [5].
Therefore, the colocalization of both AGEs and ALEs from carbohydrates, and (b) ALEs (MDA-lysine and
HNE protein adduct), derived mainly from lipids. All ofsuggests not only an increased local oxidative stress, but
also an increased carbonyl modification of proteins in the protein adducts formed by carbonyl amine chemistry
were identified immunohistochemically in the character-diabetic glomerular lesions. To address this hypothesis,
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istic DN lesions, that is, the expanded mesangial matrix man and rat mesangial cells exposed to carbonyl com-
pounds (abstract; Yasuda et al, J Am Soc Nephroland nodular lesions (exemplified for CML and MDA-
9:645A, 1998).lysine in Fig. 1 A, B, D and E, respectively). On the other
hand, their immunostainings were faint in nondiabetic
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Thus, the metabolic and chemical imbalances charac-
teristic in diabetic glomerular lesions might be described
APPENDIXmore appropriately as carbonyl stress rather than ad-
vanced glycation or oxidative stress alone. Carbonyl Abbreviations used in this article are: AGE, advanced glycation
end product; ALE, advanced lipoxidation end product; CML, Ne-(car-stress implicates a much broader derangement in nonen-
boxymethyl)lysine; DN, diabetic nephropathy; HNE, 4-hydroxy-
zymatic biochemistry that involves both lipids and carbo- nonenal; MDA, malondialdehyde.
hydrates.
REFERENCES
1. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCancePATHOLOGICAL SIGNIFICANCE OF
DR, Baynes JW: Accumulation of Maillard reaction products inCARBONYL STRESS IN THE DEVELOPMENT skin collagen in diabetes and aging. J Clin Invest 91:2463–2469, 1993
2. Sugiyama S, Miyata T, Ueda Y, Tanaka H, Maeda K, KawashimaOF DIABETIC GLOMERULAR LESIONS
S, van Ypersele de Strihou C, Kurokawa K: Plasma level of
The presence of carbonyl stress suggests its role in the pentosidine, an advanced glycation end product, in diabetic patients.
J Am Soc Nephrol 9:1681–1688, 1998development of diabetic glomerular lesions. Indeed, the
3. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, BaynesAGE- or ALE-modified proteins stimulate a variety of
JW, Lyons TJ: Maillard reaction products and their relation to
cellular responses, including glomerular mesangial cells complications in insulin-dependent diabetes mellitus. J Clin Invest
91:2470–2478, 1993[6–8]. Furthermore, carbonyl stress not only induces in-
4. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, vanflammatory responses, but may also have direct biologi- Ypersele de Strihou C, Monnier VM, Witztum JL, Kurokawa K:
cal effects on cells. As most of the carbonyl compounds Immunohistochemical colocalization of glycoxidation products and
lipid peroxidation products in diabetic renal glomerular lesions.have more than two carbonyl groups within the moiety,
J Clin Invest 100:2995–3004, 1997
they might covalently cross-link matrix tissue proteins 5. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW:
Alterations in nonenzymatic biochemistry in uremia: Origin andand alter their structure and function, or they might
significance of “carbonyl stress” in long-term uremic complications.cross-link cell surface proteins and stimulate cellular re- Kidney Int 55:389–399, 1999
sponses. We recently demonstrated the increased intra- 6. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara
H: Human and rat mesangial cell receptors for glucose-modifiedcellular protein-tyrosine phosphorylation in murine thy-
proteins: Potential role in kidney tissue remodeling and diabeticmocytes and fibroblasts by interaction with carbonyl nephropathy. J Exp Med 174:931–939, 1991
7. Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maedacompounds, such as glyoxal and MDA [9]. This increased
K, Seo H: Involvement of b2-microglobulin modified with advancedprotein-tyrosine phosphorylation may be attributed to
glycation end products in the pathogenesis of hemodialysis-associ-
the cross-linking of cell surface proteins and the subse- ated amyloidosis: Induction of human monocyte chemotaxis and
macrophage secretion of tumor necrosis factor-a and interleukin-1.quent activation of some protein tyrosine kinase, such
J Clin Invest 93:521–528, 1994as c-Src [9]. The protein-tyrosine phosphorylation in mu- 8. Miyata T, Hori O, Zhang J, Yan SD, Ferran L, Iida Y, Schmidt
rine thymocytes and fibroblasts by interaction with car- AM: The receptor for advanced glycation end products (RAGE)
is a central mediator of the interaction of AGE-b2-microglobulinbonyl compounds is inhibited by pretreatment with 2-iso-
with human mononuclear phagocytes via an oxidant-sensitive path-
propylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide way. J Clin Invest 98:1088–1094, 1996
9. Akhand AA, Kato M, Suzuki H, Hamaguchi M, Miyata T, Kuro-(OPB-9195), an inhibitor of carbonyl-amine reactions
kawa K, Nakashima I: Carbonyl stress modifies cell surface proteins[5, 9]. A number of intracellular proteins are also phos- for activating protein-tyrosine kinase p60c-Src. J Cell Biochem 72:1–7,
phorylated on tyrosine residues in primary cultured hu- 1999
